Phase I Study of Irofulven (MGI 114), an
Phase I Study of Irofulven (MGI 114), an Acylfulvene Illudin Analog, in Patients with Acute Leukemia
โ
Francis Giles; Jorge Cortes; Guillermo Garcia-Manero; Stephen Kornblau; Elihu Es
๐
Article
๐
2001
๐
Springer US
๐
English
โ 67 KB